Do You Like Terns Pharmaceuticals Inc (NASDAQ:TERN) At $2.88?

In last trading session, Terns Pharmaceuticals Inc (NASDAQ:TERN) saw 0.75 million shares changing hands with its beta currently measuring -0.24. Company’s recent per share price level of $2.88 trading at $0.09 or 3.23% at ring of the bell on the day assigns it a market valuation of $251.53M. That closing price of TERN’s stock is at a discount of -295.83% from its 52-week high price of $11.40 and is indicating a premium of 35.07% from its 52-week low price of $1.87. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 0.87 million shares which gives us an average trading volume of 1.10 million if we extend that period to 3-months.

For Terns Pharmaceuticals Inc (TERN), analysts’ consensus is at an average recommendation of Buy while assigning it a mean rating of 1.44. Splitting up the data highlights that, out of 5 analysts covering the stock, 0 rated the stock as a Sell while 0 recommended an Overweight rating for the stock. 2 suggested the stock as a Hold whereas 3 see the stock as a Buy. 0 analyst(s) advised it as an Underweight. The company is expected to be making an EPS of -0.29 in the current quarter.

Terns Pharmaceuticals Inc (NASDAQ:TERN) trade information

Upright in the green during last session for gaining 3.23%, in the last five days TERN remained trading in the red while hitting it’s week-highest on Monday, 05/12/25 when the stock touched $2.88 price level, adding 11.93% to its value on the day. Terns Pharmaceuticals Inc’s shares saw a change of -48.01% in year-to-date performance and have moved -5.26% in past 5-day. Terns Pharmaceuticals Inc (NASDAQ:TERN) showed a performance of 28.57% in past 30-days. Number of shares sold short was 5.42 million shares which calculate 4.07 days to cover the short interests.

Wall Street analysts have assigned a consensus price target of 20 to the stock, which implies a rise of 85.6% to its current value. Analysts have been projecting 20 as a low price target for the stock while placing it at a high target of 20. It follows that stock’s current price would drop -594.44% in reaching the projected high whereas dropping to the targeted low would mean a loss of -594.44% for stock’s current value.

Weighing up company’s earnings over the past 5-year and in the next 5-year periods, we find the company posting an annual earnings growth rate of 16.38% during past 5 years. In 2025, company’s earnings growth rate is likely to be around -6.49% while estimates for its earnings growth in next 5 years are of -7.23%.

Terns Pharmaceuticals Inc (NASDAQ:TERN)’s Major holders

Insiders are in possession of 0.25% of company’s total shares while institution are holding 100.04 percent of that, with stock having share float percentage of 100.30%. Investors also watch the number of corporate investors in a company very closely, which is 100.04% institutions for Terns Pharmaceuticals Inc that are currently holding shares of the company. ORBIMED ADVISORS LLC is the top institutional holder at TERN for having 7.62 million shares of worth $51.89 million. And as of 2024-06-30, it was holding 10.2326 of the company’s outstanding shares.

The second largest institutional holder is VIVO CAPITAL, LLC, which was holding about 6.18 million shares on 2024-06-30. The number of shares represents firm’s hold over 8.3038 of outstanding shares, having a total worth of $42.11 million.

On the other hand, VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund and iShares Trust-iShares Russell 2000 ETF are the top two Mutual Funds which own company’s shares. As of Dec 31, 2024 , the former fund manager was holding 2.07 shares of worth $5.97 million or 2.37% of the total outstanding shares. The later fund manager was in possession of 1.87 shares on Mar 31, 2025 , making its stake of worth around $5.38 million in the company or a holder of 2.14% of company’s stock.

Marketing Sentinel
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.